Assignee
RECURIUM IP HOLDINGS LLC
US·25 granted patents·37 pending applications·20 citations·filing 2016–2025
Top patents by PatentIndex Score
62 records- 0196US11813260B1Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2023·Granted Nov 14, 2023·1 cites·20 claims
- 0295US11339162B1Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2021·Granted May 24, 2022·3 cites·30 claims
- 0393US11813259B2Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2022·Granted Nov 14, 2023·1 cites·17 claims
- 0491US11261192B2Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Mar 1, 2022·5 cites·27 claims
- 0589US2024180899A1Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2023·Application pending·0 cites
- 0687US11590126B2Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Feb 28, 2023·1 cites·97 claims
- 0787US11344546B2Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted May 31, 2022·1 cites·109 claims
- 0883US11065234B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Jul 20, 2021·1 cites·32 claims
- 0982US11098030B2EGFR inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Aug 24, 2021·1 cites·13 claims
- 1082US10525036B2Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2016·Granted Jan 7, 2020·2 cites·23 claims
- 1181US11278532B2Estrogen receptor modulators for treating mutantsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Mar 22, 2022·1 cites·22 claims
- 1280US2024391924A1Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 1379US11124518B2L,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-one analogsRECURIUM IP HOLDINGS LLC·Filed 2018·Granted Sep 21, 2021·2 cites·22 claims
- 1479US2026028363A1Chiral synthesis of a tertiary alcoholRECURIUM IP HOLDINGS LLC·Filed 2025·Application pending·0 cites
- 1576US10793504B2Methods for cross couplingRECURIUM IP HOLDINGS LLC·Filed 2017·Granted Oct 6, 2020·1 cites·22 claims
- 1674US11318134B2Benzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted May 3, 2022·0 cites·82 claims
- 1773US12049460B2EGFR inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2021·Granted Jul 30, 2024·0 cites·20 claims
- 1873US2021330651A1Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 1972US10959989B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Mar 30, 2021·0 cites·3 claims
- 2071US10975035B2Bicyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Apr 13, 2021·0 cites·25 claims
- 2170US11999728B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2022·Granted Jun 4, 2024·0 cites·18 claims
- 2270US11065233B2Estrogen receptor modulatorsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Jul 20, 2021·0 cites·24 claims
- 2369USRE50643EBenzamide compoundsRECURIUM IP HOLDINGS LLC·Filed 2019·Granted Oct 21, 2025·0 cites·100 claims
- 2469US2022024939A1Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-onesRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 2566US12410204B2Chiral synthesis of a tertiary alcoholRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Sep 9, 2025·0 cites·19 claims
- 2666US11724971B2Process for making [1.1.1]propellaneRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Aug 15, 2023·0 cites·21 claims
- 2766US2024261295A1Combinations of wee1 inhibitors and anti-cd47 antibodiesRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 2864US2024299395A1Combination therapies comprising wee1 inhibitors and dna damage response (ddr) inhibitorsRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 2964US2024325397A1Use of combination therapy for treating cancerRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 3063US2020268714A1Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 3163US2024325412A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 3263US2024335447A1Wee1 inhibitor for cancerRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 3362US2021317124A11,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-one analogsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 3462US2021115058A1Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 3561US2024408097A1Wee1 inhibitors and methods for treating cancerRECURIUM IP HOLDINGS LLC·Filed 2023·Application pending·0 cites
- 3661US2022125769A1Estrogen receptor modulators for treating mutantsRECURIUM IP HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 3760US10934304B2Spirocyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2017·Granted Mar 2, 2021·0 cites·23 claims
- 3858US2024197743A1Wee1 compound for treating uterine serous carcinomaRECURIUM IP HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 3956US2023167105A1Bcl-2 protein inhibitorsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4056US2023381172A1Combinations of bcl-2 inhibitors with chemotherapeutic agentsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4154US10653681B2Analgesic compoundsRECURIUM IP HOLDINGS LLC·Filed 2017·Granted May 19, 2020·0 cites·12 claims
- 4254US2023210854A1Mono- and combination therapiesRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4354US2023234956A1Methods of making wee1 inhibitor compoundsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4454US2023159416A1Difluoromethyl iodo compounds and methodsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4554US2023158048A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4653US11339103B2Continuous flow processes for making bicyclic compoundsRECURIUM IP HOLDINGS LLC·Filed 2018·Granted May 24, 2022·0 cites·31 claims
- 4753US2023065577A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 4853US2023212118A1Preparation of an selective estrogen receptor degraderRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4952US2022265834A1Bcl-2 protein inhibitorsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 5052US2023054854A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →